Igor I Slukvin

This inventor holds 32 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Wisconsin Alumni Research Foundation, Cynata Therapeutics Limited, Other. Active years: 2009-2026.

USPTO Granted Patents = 32 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 101(Granted Patents)

Location History:

Madison, WI (US) (2016 - 2017)
Verona, WI (US) (2009 - 2023)

Company Filing History:

28 out of 4,234

Wisconsin Alumni Research Foundation

patents

3 out of 4

Cynata Therapeutics Limited

patents

1 out of 834,350

Other

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Pluripotent Stem Cells

Microglia Derivation

Vasculogenic Cell Populations

Hemogenic Endothelium

Erythroid Cells

Angiohematopoietic Progenitor Cells

Lymphohematopoietic Progenitor Cells

Dendritic Cells

Transcription Factors

MAPK/ERK Signaling

Induced Pluripotent Stem Cells

Mesenchymal Stem Cells

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12606798 - Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions (2026-04-21),

2. 12545889 - COLONY FORMING MEDIUM AND USE THEREOF (2026-02-10),

3. 12454676 - Derivation of human microglia from pluripotent stem cells (2025-10-28),

4. 12410401 - Generation of functional neutrophils and macrophages from induced pluripotent stem cells in chemically defined conditions using transient expression of ETV2 (2025-09-09),

5. 12098390 - Generating vasculogenic cell populations (2024-09-24),

6. 11591571 - Pluripotent stem cell assay (2023-02-28),

7. 11499137 - Induction of hemogenic endothelium from pluripotent stem cells by forced expression of transcription factors (2022-11-15),

8. 11345895 - Induction of arterial-type of hemogenic endothelium (AHE) and enhancement of T cell production from PSCs through overexpression of ETS factors or modulating MAPK/ERK signalling pathways (2022-05-31),

9. 11174461 - Colony forming medium and use thereof (2021-11-16),

10. 11124765 - Derivation of human microglia from pluripotent stem cells (2021-09-21),

11. 11091738 - Generating vasculogenic cell populations (2021-08-17),

12. 10982192 - Method for the induction of arterial-type of hemogenic endothelium from hPSCS (2021-04-20),

13. 10724002 - Erythroid cells producing adult-type beta-hemoglobin generated from human embryonic stem cells (2020-07-28),

14. 10260047 - Angiohematopoietic progenitor cells (2019-04-16),

15. 10106771 - Induction of hemogenic endothelium from pluripotent stem cells by forced expression of transcription factors (2018-10-23),

Title: Igor I Slukvin - Pioneering Inventor from Verona, WI

Introduction: Igor I Slukvin is a renowned inventor based in Verona, Wisconsin, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Igor I Slukvin holds several patents in various technological domains, showcasing his versatility and expertise in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Igor I Slukvin has consistently pushed the boundaries of innovation, with a focus on developing solutions that have the potential to revolutionize industries and improve the quality of life for people around the world.

Collaborations: Igor I Slukvin has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams to achieve remarkable results.

Conclusion: Igor I Slukvin's passion for innovation, coupled with his dedication to creating impactful solutions, solidifies his position as a trailblazing inventor whose work continues to inspire and shape the future of technology.